First in state treatments | New residencey program | Silver Elite Seminars

February 2019

Lovelace Women's Hospital treating uterine fibroids

Lovelace Women’s Hospital is the only hospital in the state of New Mexico now treating uterine fibroids, safely and effectively, with Acessa ProVu System™, a fully-integrated radiofrequency ablation, ultrasounds visualization, and guidance mapping system.

Uterine fibroids are non-cancerous growths in the uterus and affect 70% of women under the age of 55. Twenty five percent of those women experience significant symptoms from their fibroids. Historically, a hysterectomy has been the primary treatment for uterine fibroids. The Acessa Procedure™ is a safe, effective, and minimally invasive alternative. It requires no cutting or suturing or uterine tissue and patients typically go home the same day, experiencing minimal discomfort and a rapid return to normal activities.

Dr. Carrie Swartz of Bosque Women’s Care is performing the Acessa Procedure™ at Lovelace Women’s Hospital.

First stent in NM performed at Heart Hospital

The first ever Eluvia ™ Drug-Eluting Stent, in the New Mexico was recently performed at Heart Hospital of New Mexico at Lovelace Medical Center by New Mexico Heart Institute/Lovelace Medical Group vascular surgeon, Steven Henao, MD, FACC, FACS.

The Eluvia Drug-Eluting Stent is designed to restore blood flow in the peripheral arteries above the knee, including the superficial femoral artery and proximal popliteal artery. Its unique design features the sustained release of the drug (paclitaxel) that can prevent narrowing of the vessel, often the cause of pain and disability for patients diagnosed with peripheral artery disease (PAD).

PAD affects approximately 8.5 million Americans over the age of 40. The prevalence of the disease increases with age for both men and women, and if an individual’s PAD is caused by a buildup of plaques in blood vessels, they may be at risk of developing critical limb ischemia (CLI), stroke or heart attack, so proper treatment can play a vital role in managing the disease.

Lovelace welcomes two new providers 

Crystal Lewis-Hicks, MSN, FNP-C Joins New Mexico Heart Institute/Lovelace Medical Group

Crystal Lewis-Hicks, MSN, FNP-C, is a certified family nurse practitioner with over 12 years’ experience in multiple areas include ICU, Cath Lab, OR, Case Management and an educator in the field of nursing. She received her associate of science degree in nursing from Eastern New Mexico University in Roswell, NM before completing her master of nursing degree from Walden University in Minneapolis, MN. Crystal is a member of the American Academy of Nurse Practitioners.


Fenton McCarthy, M.D., M.S. Joins New Mexico Heart Institute/Lovelace Medical Group

Fenton McCarthy, M.D., M.S. is a board eligible cardiothoracic surgeon and a member of the Society for Thoracic Surgeons.

Dr. McCarthy was born and raised in Colorado. He received his bachelor of arts in history and Spanish literature from Dartmouth College. He briefly studied and lived in Latin America before completing his medical degree, Integrated Cardiothoracic Surgery Residency, and master of science from the University of Pennsylvania.

To schedule an appointment with either provider call 841.1000.

Copyright © 2019 Lovelace Health System
Our address is 4101 Indian School Rd NE, Albuquerque, NM 87110, USA